Last checked at 10 Mar 2021 15:13
FORM 8.3
Amendment to purchase and sales
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 08 March 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
1,795,248 | 1.39% | 182,081 | 0.14% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
103,127 | 0.08% | 7,066 | 0.01% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 6,100 | 0.00% | 6,100 | 0.00% | |
|
|
|
| ||
(4) | TOTAL: |
|
|
|
|
1,904,475 | 1.48% | 195,247 | 0.15% | ||
|
|
|
| ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
| Purchase | 1 | 225.2000 USD |
| Purchase | 1 | 225.3000 USD |
| Purchase | 1 | 225.4900 USD |
| Purchase | 2 | 228.3000 USD |
| Purchase | 3 | 225.8500 USD |
| Purchase | 4 | 225.6400 USD |
| Purchase | 4 | 225.7300 USD |
| Purchase | 8 | 226.0300 USD |
| Purchase | 9 | 227.6966 USD |
| Purchase | 90 | 228.1100 USD |
| Purchase | 99 | 225.4100 USD |
| Purchase | 100 | 228.3200 USD |
| Purchase | 100 | 228.6600 USD |
| Purchase | 120 | 225.2200 USD |
| Purchase | 188 | 229.0112 USD |
| Purchase | 200 | 228.7920 USD |
| Purchase | 300 | 226.4766 USD |
| Purchase | 872 | 229.4060 USD |
| Purchase | 1,077 | 228.6205 USD |
| Purchase | 1,642 | 227.4367 USD |
| Purchase | 1,702 | 227.3585 USD |
| Purchase | 2,197 | 227.0776 USD |
| Purchase | 2,577 | 225.4046 USD |
| Purchase | 2,928 | 225.2310 USD |
| Purchase | 4,704 | 225.2300 USD |
| Purchase | 13,278 | 226.7660 USD |
| Sale | 2 | 228.8800 USD |
| Sale | 8 | 226.0300 USD |
| Sale | 28 | 229.9500 USD |
| Sale | 42 | 228.2400 USD |
| Sale | 100 | 230.0800 USD |
| Sale | 100 | 229.6300 USD |
| Sale | 100 | 228.9700 USD |
| Sale | 108 | 226.0462 USD |
| Sale | 148 | 227.9164 USD |
| Sale | 180 | 225.2200 USD |
| Sale | 200 | 226.6280 USD |
| Sale | 245 | 225.2355 USD |
| Sale | 264 | 228.3561 USD |
| Sale | 382 | 228.0600 USD |
| Sale | 410 | 228.9938 USD |
| Sale | 872 | 229.4060 USD |
| Sale | 1,115 | 227.5608 USD |
| Sale | 1,260 | 227.2477 USD |
| Sale | 1,331 | 228.2548 USD |
| Sale | 1,332 | 225.2322 USD |
| Sale | 1,396 | 227.2163 USD |
| Sale | 2,248 | 225.2299 USD |
| Sale | 2,366 | 228.1324 USD |
| Sale | 2,575 | 225.4019 USD |
| Sale | 2,765 | 227.7197 USD |
| Sale | 3,197 | 227.0478 USD |
| Sale | 4,254 | 225.2300 USD |
| Sale | 12,246 | 226.6263 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | YES |
| Date of disclosure: | 10 Mar 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
|
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
| Product name | Written or | Number of | Exercise | Type | Expiry |
| purchased | relevant securities | price |
| date |
|
| to which the option |
|
|
|
|
| or derivative |
|
|
|
|
| relates |
|
|
|
Put Options | Purchased | -100 | 220.0000 | American | Jul 16, 2021 |
Call Options | Purchased | 100 | 240.0000 | American | Jul 16, 2021 |
Call Options | Purchased | 6,000 | 220.0000 | American | Jul 16, 2021 |
Put Options | Purchased | -6,000 | 200.0000 | American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210310005663/en/
Copyright Business Wire 2021